Foundation has distinguished excellence in biomedical research in Europe by awarding a Prize to exceptional Scientists whose innovative research has advanced medicine. Rather than marking past achievements, the Louis Jeantet Prize aims to encourage and support innovative ongoing research projects. Over the years, many exceptional researchers have received such a distinction in areas as diverse as immunology, virology, bacteriology, neurobiology, clinical epidemiology and structural biochemistry. This year is no exception, as the grantees are internationally recognized for their work in regulatory T cells for Fiona Powrie For the third time, EMBO Molecular Medicine is delighted to publish commentaries from this year's winners, 'Gut reactions: Immune pathways in the intestine in health and disease' (Powrie, 2012) and 'Proteomics for biomedicine: A half-completed journey' (Mann, 2012 Chemistry in 2002) . This pioneering work paved the way to modern proteomics, the global analysis of proteins. Over the last 25 years, the field of proteomics has evolved so much that it is now possible to detect and characterize with high sensitivity thousands of proteins, mapping structure and function globally onto any biological system. Recent advances, both in terms of instrumentation, computational analysis and sample preparation, to which the Mann lab has critically contributed, allow for accurate quantification of proteins across varying conditions. Proteomic applications in medicine range from the characterization of differential proteomes between normal and disease state to tissue specific proteomes, including formalin-fixed samples, or marker of expression in body fluids such as urine or plasma. Modern mass spectrometry techniques are capable of identifying different post-translational modifications or diverse protein interactions. With these progresses, proteomics can now be successfully applied to all areas of research and medicine and be used to identify specific markers of a disease, progression stage and potential drug resistance. One famous discovery of the Mann's lab is SILAC (stable isotope labelling by amino acids in cell culture), the most accurate proteome quantification method, enabling detection and characterization of proteins via their interactions, modifications and cellular localizations. Recently Matthias Mann's group reported the proteome of a single cancer cell type, thereby providing proof of principle for clinical proteomics which will allow very precisely quantifying and cataloguing thousands of proteins that may be used as biomarkers or protein signatures to guide clinicians in diagnosis, prognosis and better adapted treatment of human diseases. This is the 
